Frontal presentation of Alzheimer's disease: A series of patients with biological evidence by CSF biomarkers

28Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

Abstract

Besides its typical amnesic presentation, focal atypical presentations of Alzheimer's disease (AD) have been described in neuropathological studies. These phenotypical variants of AD (so-called "atypical AD") do not follow the typical amnestic pattern and include non-amnestic focal cortical syndromes, such as posterior cortical atrophy and frontal variant AD. These variants exhibit characteristic histological lesions of Alzheimer pathology at post-mortem exam. By using physiopathological markers, such as cerebrospinal fluid markers, it is now possible to establish in vivo a biological diagnosis of AD in these focal cortical syndromes. We report a series of eight patients who were diagnosed with behavioural variant frontotemporal dementia based on their clinical, neuropsychological and neuroimaging findings, while CSF biomarkers showed an AD biological profile, thus supporting a diagnosis of frontal variant of AD.

Cite

CITATION STYLE

APA

de Souza, L. C., Bertoux, M., Funkiewiez, A., Samri, D., Azuar, C., Habert, M. O., … Dubois, B. (2013). Frontal presentation of Alzheimer’s disease: A series of patients with biological evidence by CSF biomarkers. Dementia e Neuropsychologia, 7(1), 66–74. https://doi.org/10.1590/s1980-57642013dn70100011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free